Hosted on MSN11mon
Obsidian raises $160.5m to advance TIL cell therapy programmeObsidian Therapeutics has raised $160.5m in a ... In the melanoma trial (NCT05470283), which is being sponsored by the MD Anderson Cancer Centre, OBX-115 is being administered in combination ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback